Endomyocardial Fibrosis in Restrictive Cardiomyopathy with Survived Cardiac Arrest

Clinical Scenario

This protocol applies to patients with restrictive cardiomyopathy who have survived a cardiac arrest, or who have recovered from a ventricular arrhythmia causing haemodynamic instability — a high-risk subgroup requiring specific intervention to address sudden cardiac death risk.

Treatment Approach

Management in this setting involves an implantable device-based intervention aimed at reducing the risk of sudden death and all-cause mortality. The complete structured protocol — including precise indication criteria and procedural guidance — is available via the link below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1093/eurheartj/ehad194

ICD implantation is recommended to reduce the risk of sudden death and all-cause mortality in patients with RCM who have survived a cardiac arrest or have recovered from a ventricular arrhythmia causing haemodynamic instability.

View source ↗